Literature DB >> 16332588

IAEA's role in the global management of cancer-focus on upgrading radiotherapy services.

Eeva Salminen1, Joanna Izewska, Pedro Andreo.   

Abstract

The International Atomic Energy Agency (IAEA) is an intergovernmental organization composed by 138 Member States within the United Nations. It has a mandate to seek to accelerate and enlarge the contribution of atomic energy to peace, health and prosperity throughout the world. Within the IAEA structure, the Division of Human Health contributes to the enhancement of the capabilities in Member States to address needs related to prevention, diagnosis and treatment of health problems through the development and application of nuclear and radiation techniques within a framework of quality assurance. In view of the increasing cancer incidence rates in developing countries the activities in improving management of cancer have become increasingly important. This review will outline the IAEA's role in cancer management focusing on activities related to improving radiotherapy worldwide.

Entities:  

Mesh：

Year:  2005        PMID： 16332588     DOI： 10.1080/02841860500341355

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


  9 in total

1.  Initial care and outcome of glioblastoma multiforme patients in 2 diverse health care scenarios in Brazil: does public versus private health care matter?.

Authors:  Luiz Victor Maia Loureiro; Lucíola de Barros Pontes; Donato Callegaro-Filho; Ludmila de Oliveira Koch; Eduardo Weltman; Elivane da Silva Victor; Adrialdo José Santos; Lia Raquel Rodrigues Borges; Roberto Araújo Segreto; Suzana Maria Fleury Malheiros
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

Review 2.  Cancer vaccines: on the threshold of success.

Authors:  Leisha A Emens
Journal:  Expert Opin Emerg Drugs       Date:  2008-06       Impact factor: 4.191

3.  Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency.

Authors:  Timothy P Hanna; Alfred C T Kangolle
Journal:  BMC Int Health Hum Rights       Date:  2010-10-13

4.  Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patients.

Authors:  Nai-Si Huang; Meng-Ying Liu; Jia-Jian Chen; Ben-Long Yang; Jing-Yan Xue; Chen-Lian Quan; Miao Mo; Guang-Yu Liu; Zhen-Zhou Shen; Zhi-Min Shao; Jiong Wu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 5.  "Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries".

Authors:  Mahmoud Aljurf; Daniel Weisdorf; Feras Alfraih; Jeff Szer; Carlheinz Müller; Dennis Confer; Shahrukh Hashmi; Nicolaus Kröger; Bronwen E Shaw; Hildegard Greinix; Mohamed A Kharfan-Dabaja; Lydia Foeken; Adriana Seber; Syed Ahmed; Areej El-Jawahri; Moheeb Al-Awwami; Yoshiko Atsuta; Marcelo Pasquini; Amr Hanbali; Hazzaa Alzahrani; Shinichiro Okamoto; Eliane Gluckman; Mohamad Mohty; Yoshihisa Kodera; Mary Horowitz; Dietger Niederwieser; Riad El Fakih
Journal:  Bone Marrow Transplant       Date:  2019-02-18       Impact factor: 5.483

6.  Design and Synthesis of Benzene Homologues Tethered with 1,2,4-Triazole and 1,3,4-Thiadiazole Motifs Revealing Dual MCF-7/HepG2 Cytotoxic Activity with Prominent Selectivity via Histone Demethylase LSD1 Inhibitory Effect.

Authors:  Mosa Alsehli; Ateyatallah Aljuhani; Saleh K Ihmaid; Shahenda M El-Messery; Dina I A Othman; Abdel-Aziz A A El-Sayed; Hany E A Ahmed; Nadjet Rezki; Mohamed R Aouad
Journal:  Int J Mol Sci       Date:  2022-08-08       Impact factor: 6.208

Review 7.  A Socio-Ecological Framework for Cancer Prevention in Low and Middle-Income Countries.

Authors:  Tomi Akinyemiju; Kemi Ogunsina; Anjali Gupta; Iris Liu; Dejana Braithwaite; Robert A Hiatt
Journal:  Front Public Health       Date:  2022-05-26

8.  The MIF -173G/C gene polymorphism increase gastrointestinal cancer and hematological malignancy risk: evidence from a meta-analysis and FPRP test.

Authors:  Xiang Tong; Bing Zheng; Qiaoyi Tong; Sitong Liu; Sifeng Peng; Xin Yang; Hong Fan
Journal:  Int J Clin Exp Med       Date:  2015-09-15

9.  Shikonin and 4-hydroxytamoxifen synergistically inhibit the proliferation of breast cancer cells through activating apoptosis signaling pathway in vitro and in vivo.

Authors:  Hong-Yan Lin; Hong-Wei Han; Yin-Song Wang; De-Liu He; Wen-Xue Sun; Lu Feng; Zhong-Ling Wen; Min-Kai Yang; Gui-Hua Lu; Xiao-Ming Wang; Jin-Liang Qi; Yong-Hua Yang
Journal:  Chin Med       Date:  2020-03-10       Impact factor: 5.455
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.